OCS Lung Expand Post-Approval Study - Expand Follow-Up Data Collection
NCT04194398 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 79
Last updated 2022-04-07
Summary
Collection of five year follow-up data on patients who have already participated in the EXPAND Lung trial and have had transplants with donor lungs preserved on the OCS Lung System.
Conditions
- OCS Lung System
Interventions
- DEVICE
-
OCS Lung System
Patients previously transplanted with lungs preserved on the OCS Lung System in the Expand Lung study.
Sponsors & Collaborators
-
TransMedics
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-12-31
- Primary Completion
- 2021-09-30
- Completion
- 2021-09-30
- FDA Device
- Yes
Countries
- United States
- Belgium
- Germany
Study Locations
More Related Trials
-
Non-respiratory Comorbidities Observed in Pulmonary French Transplant Patients With Cystic Fibrosis
NCT03357913 ·Status: COMPLETED
-
Needs in Education for Pulmonary or Cardiopulmonary Transplanted Cystic Fibrosis Patients
NCT01285895 ·Status: COMPLETED
-
Breath Condensate Study in Patients With Cystic Fibrosis.
NCT02056132 ·Status: COMPLETED
-
Metabolic Efficiency of Combined Pancreatic Islet and Lung Transplant for the Treatment of End-Stage Cystic Fibrosis
NCT01548729 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Development of Diabetes in Adults With Cystic Fibrosis (CF)
NCT03644199 ·Status: WITHDRAWN ·Phase: NA
-
Host and Bacterial Mechanisms During Cystic Fibrosis Pulmonary Exacerbations
NCT04354038 ·Status: COMPLETED
-
Cystic Fibrosis and Fit-to-Fly
NCT03843723 ·Status: COMPLETED
-
Analysis of Remote Monitoring/Virtual Clinic Data in Adult Patients With Cystic Fibrosis (Project Breathe)
NCT06222905 ·Status: ACTIVE_NOT_RECRUITING
-
Early Intervention in Cystic Fibrosis Exacerbation
NCT01104402 ·Status: COMPLETED ·Phase: NA
-
Extracorporeal Photopheresis (ECP) After Lung Transplantation
NCT05721079 ·Status: COMPLETED ·Phase: NA
-
Nutritional, Metabolic and Respiratory Status in Cystic Fibrosis
NCT00476281 ·Status: COMPLETED ·Phase: NA
-
HFNT During Exercise in CF
NCT03965832 ·Status: COMPLETED ·Phase: NA
-
Bacterial Gene Profiling to Predict Antibiotic Resistance During Cystic Fibrosis Pulmonary Exacerbations
NCT04341532 ·Status: COMPLETED
-
The Use of Breath Volatile Organic Compounds in Early Detection of Acute Pulmonary Exacerbations in Cystic Fibrosis
NCT05944367 ·Status: COMPLETED
-
Volatilomic Approaches for the Study of CFTR Modulators (VOLATIL-CF)
NCT05726994 ·Status: UNKNOWN
-
Regional Monitoring of CF Lung Disease
NCT06339593 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Evaluating Sensations of Breathlessness in Patients With Cystic Fibrosis
NCT01799642 ·Status: COMPLETED
-
Lung Transplant READY CF 2: A Multi-site RCT
NCT06030206 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Upper and Lower Airway Colonization in Cystic Fibrosis Patients After Lung Transplantation
NCT02591524 ·Status: UNKNOWN ·Phase: NA
-
OnTrackCF: Engagement, Feasibility, and Acceptability Study
NCT07031323 ·Status: RECRUITING ·Phase: NA
-
Lung Transplantation for Pleuroparenchymal Fibroelastosis
NCT05044390 ·Status: UNKNOWN
-
Extracorporeal Photopheresis in Lung Transplant Rejection for Cystic Fibrosis (CF) Patients
NCT03500575 ·Status: UNKNOWN ·Phase: NA
-
Lung Transplant READY CF 2: CARING CF Ancillary RCT
NCT06032273 ·Status: RECRUITING ·Phase: NA
-
Longitudinal Analysis of Respiratory and Intestinal Microbiome in Cystic Fibrosis
NCT03335202 ·Status: UNKNOWN
-
A Drug-Drug Interaction Study of FDL169 and FDL176 in Healthy Subjects
NCT03516331 ·Status: COMPLETED ·Phase: PHASE1